Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-1992 | 10-1991 | 07-1991 | 04-1991 | 01-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 821 | 843 | 828 | 833 | 862 |
| Receivables | 169 | 157 | 92 | 288 | 205 |
| Inventories | 85 | 81 | 72 | 89 | 49 |
| Other current assets | 83 | 66 | 57 | 160 | 188 |
| TOTAL | $1,158 | $1,147 | $1,048 | $1,370 | $1,304 |
| Non-Current Assets | |||||
| PPE Net | 1,250 | 1,250 | 1,242 | 1,250 | 1,221 |
| Other Non-Current Assets | 389 | 296 | 295 | 110 | 161 |
| TOTAL | $1,639 | $1,546 | $1,538 | $1,360 | $1,382 |
| Total Assets | $2,525 | $2,448 | $2,371 | $2,537 | $2,496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7 | 7 | 10 | 16 | 15 |
| Accounts payable and accrued liabilities | 269 | 240 | 344 | 528 | 570 |
| Accrued Expenses | 43 | 93 | 94 | 142 | 127 |
| Other current liabilities | 90 | 17 | 43 | 3 | 71 |
| TOTAL | $1,233 | $1,190 | $1,356 | $1,555 | $1,607 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33 | 36 | 40 | 0 | 34 |
| TOTAL | $150 | $142 | $99 | $59 | $34 |
| Total Liabilities | $1,383 | $1,332 | $1,455 | $1,649 | $1,642 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,939 | -1,933 | -1,956 | -1,984 | -2,018 |
| Other shareholders' equity | 207 | 176 | 0 | 0 | 0 |
| TOTAL | $1,141 | $1,116 | $916 | $888 | $854 |
| Total Liabilities And Equity | $2,525 | $2,448 | $2,371 | $2,537 | $2,496 |